All Type of News


7 of 10 medicines approved this year was generic

7 of 10 medicines approved this year was reportedly a generic referencing an original drug. 5 pharmaceutical companies, such as Hutecs, Binex and Hankook Korus Pharm, were observed to acquire approval for more than 3...

Daewoong Bio, “Big pharmas control selecting comparison drugs”

Daewoong Bio(CEO Byung-Gook Yang) announced on the 13th that the company filed an administrative trial to the Central Administrative Appeals Commission, which claimed ‘Cancellation of Choline Alfoscerate Comparison Dr...

Tagrisso causes complaints over issue biopsy

AstraZeneca Korea mentioned about the fact the Tagrisso’s(generic name: osimertinib) health insurance benefits will only be accepted only if a tissue biopsy is positive. Tagrisso is a novel drug which overcame EGFR-t...

‘Public & Midnight Pharmacies’ passed Seocho-gu plenary session

The Seoul’s first support ordinance for installation of public & midnight pharmacies passed the Seocho-gu plenary session. Although they have already been operated in Gyeonggi-do and Incheon, this was the first case i...

Biotech industry led ‘Pharmaceutical Industry’ last year, accounting for 35% of total

Last year, the entire biotech industry size was increased closed to KRW 9 trillion while the biopharmaceutical field led the growth by dominating about 35% of the total KRW 4.4 trillion exports. The Ministry of Trade...

Large hospitals to issue prescriptions using smart phones next year

On the 12th, the Korea Internet & Security Agency(President Suk-Hwan Kim, KISA) signed the ‘memorandum of understanding(MOU) for adopting digitalized issuing service of paper prescriptions’ with Seoul National Univers...

Big pharma medical representatives’ careful behavior, creating less pushed-in products

Unlike the last year, pharmaceutical companies have acted differently in regards to ‘pushing products in.’ Medical representatives at pharmaceutical company had forced and pushed products in to distribution companies...

“The original-generic competition in the U.S. is our future”

“The competition between original drugs and generics in the U.S. drug market is one of the import issues the Korean pharmaceutical industry must pay attention.” Marketing Director Ki-Hyun Ko(former pharmacist) at Ini...

Kuhnil first reveals Phase III clinical trial for Omega-3 & Rosuvastatin combination drug

Kuhnil(CEO Young-Joong Kim) announced the Phase III clinical trial result for ‘Rosumega SC,’ a dyslipidemia combination drug, was published in the SCI-level international journal ‘Clinical Therapeutics’ on 6 December....

Pharma industry superior in sales and total asset increases to manufacturing industry

Despite the employment cold wave, like the low employment rate for young adults, pharmaceutical companies, such as Ildong Pharmaceutical, Daewoong Pharmaceutical, Boyrung Pharm, JW Pharmaceutical and Huons, are still ...

TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.